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        Introduction 
  Differentiation of vertebrate skeletal myoblasts into multinucle-
ated myofi  bers is a multistage process that involves the coordi-
nated activation of a cell type  –  specifi  c transcriptional program 
and morphological changes that include elongation, alignment, 
and cell  –  cell fusion (  Pownall et al., 2002  ;   Tapscott, 2005  ). 
Members of the myogenic bHLH family (MyoD, Myf5, myo-
genin, and MRF4) are lineage-specifi  c transcription factors that 
direct the differentiation process in conjunction with nonskele-
tal muscle  –  specifi  c transcription factors such as Mef2 (  Pownall 
et al., 2002  ;   Tapscott, 2005  ). The activity of such factors is un-
der tight posttranslational control by signal transduction path-
ways, including the p38  /   MAPK pathway ( Lluis et al., 2006 ). 
p38   /    is activated during myogenic differentiation in vitro, 
and differentiation is blocked by chemical inhibitors of p38   /   
(  Cuenda and Cohen, 1999  ;   Zetser et al., 1999  ;   Wu et al., 2000  ). 
p38    -null myoblasts are defi  cient in cell cycle arrest, expres-
sion of muscle-specifi  c proteins, and myotube formation, and 
mice lacking p38     display delayed myofi  ber growth and matu-
ration (  Perdiguero et al., 2007  ). p38   /    directly phosphorylates 
several proteins that regulate myogenesis, including Mef2 iso-
forms, the myogenic bHLH heterodimeric partner E47, the SWI  –
  SNF chromatin remodeling complex subunit BAF60, and the RNA 
decay-promoting factor KSRP (  Wu et al., 2000  ;   Simone et al., 
2004  ;   Briata et al., 2005  ;   Lluis et al., 2005  ). 
  RD rhabdomyosarcoma cells (cancer cells of the muscle 
lineage that have low differentiation capability) are defi  cient in 
p38   /    activity in response to differentiation-inducing culture 
conditions, and enforced p38   /    activation in these cells by ex-
pression of activated MKK6 (an immediate upstream activating 
T
he p38    /     mitogen-activated protein kinase (MAPK) 
pathway promotes skeletal myogenesis, but the 
mechanisms by which it is activated during this 
process are unclear. During myoblast differentiation, the 
promyogenic cell surface receptor Cdo binds to the 
p38    /     pathway scaffold protein JLP and, via JLP, 
p38    /     itself. We report that Cdo also interacts with 
Bnip-2, a protein that binds the small guanosine triphos-
phatase (GTPase) Cdc42 and a negative regulator of 
Cdc42, Cdc42 GTPase-activating protein (GAP). More-
over, Bnip-2 and JLP are brought together through mutual 
interaction with Cdo. Gain- and loss-of-function experi-
ments with myoblasts indicate that the Cdo  –  Bnip-2 inter-
action stimulates Cdc42 activity, which in turn promotes 
p38    /     activity and cell differentiation. These results re-
veal a previously unknown linkage between a cell surface 
receptor and downstream modulation of Cdc42 activity. 
Furthermore, interaction with multiple scaffold-type pro-
teins is a distinctive mode of cell surface receptor signal-
ing and provides one mechanism for speciﬁ  city of p38    /     
activation during cell differentiation.
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Cdc42 were expressed in different myoblast cell systems have 
produced contradictory results but, in general, both mutants in-
terfered with myogenesis (  Takano et al., 1998  ;   Gallo et al., 
1999  ;   Meriane et al., 2000  ), suggesting that major perturbations 
in Cdc42 activity are not tolerated. 
  Like other small GTPases, Cdc42 cycles between an inac-
tive GDP-bound state and an active GTP-bound state. The activ-
ity cycle is directly regulated by its interaction with stimulatory 
guanine nucleotide exchange factors and inhibitory GTPase-
  activating proteins (GAPs) and by interaction with additional 
proteins (  Van Aelst and D  ’  Souza-Schorey, 1997  ;   Jaffe and Hall, 
2005  ). A candidate regulator of Cdc42 is Bnip-2 (  Low et al., 
1999  ,   2000a  ,  b  ). Bnip-2 is a 314-aa protein that harbors a single 
recognizable motif, a BCH domain that spans its C-terminal half. 
Cdc42GAP (also known as p50RhoGAP/ARHGAP1) contains a 
BCH domain in its noncatalytic N-terminal region, and Bnip-2 
and Cdc42GAP interact via their respective BCH domains (  Low 
et al., 1999  ,   2000b  ). The Bnip-2 BCH domain also binds Cdc42 
itself (  Low et al., 2000a  ). Transient expression of Bnip-2 in sev-
eral cell types induces cellular elongation and membrane protru-
sions in a manner dependent on its ability to bind Cdc42 and on 
cellular Cdc42 activity (  Zhou et al., 2005  ). That Bnip-2 binds 
Cdc42GAP, a negative regulator of Cdc42, yet has the ability to 
induce morphological alterations that require Cdc42 binding and 
Cdc42 activity, suggests that Bnip-2 might function as a scaffold 
for dynamic regulation of Cdc42 signaling. However, modulation 
of cellular Cdc42 activity by Bnip-2 has not been demonstrated. 
  Cdo is a cell surface receptor of the Ig superfamily that 
promotes myogenesis in vivo and in vitro (  Kang et al., 1998  , 
  2003  ;   Cole et al., 2004  ). Primary myoblasts from   Cdo 
   /       mice 
and C2C12 myoblasts that express   Cdo   siRNA differentiate de-
fectively in culture, producing reduced levels of muscle-specifi  c 
proteins and fusing into myotubes ineffi  ciently ( Cole et al., 2004 ; 
  Takaesu et al., 2006  ). During myogenesis, the Cdo intracellular 
region binds to JLP, a scaffold protein for the p38   /    MAPK 
pathway and, via JLP, p38   /    (  Takaesu et al., 2006  ).   Cdo 
   /      
myoblasts are defi  cient in differentiation-associated p38   /    ac-
tivity, and their differentiation defect is specifi  cally rescued by 
expression of activated MKK6 (  Takaesu et al., 2006  ); however, 
how association of JLP/p38   /    with Cdo leads to activation of 
p38   /    is unknown. We report in this paper that the Cdo intra-
cellular region binds Bnip-2 and that this interaction regulates 
Cdc42 activity, thus identifying a novel linkage between a cell 
surface receptor and regulation of Cdc42. Bnip-2 and JLP do not 
directly associate but are brought together through mutual inter-
action with Cdo, and Bnip-2 and Cdc42 stimulate p38   /    acti-
vation and myogenic differentiation. Interaction with multiple 
scaffold-type proteins is an unusual mode of cell surface recep-
tor signaling and provides a mechanism by which p38   /    can  be 
specifi  cally activated to promote cell differentiation. 
  Results 
  Cdo interacts with Bnip-2 
  A yeast two-hybrid screen that used the Cdo intracellular region 
as bait previously identifi  ed JLP as a Cdo-interacting protein 
( Takaesu et al., 2006 ). This screen also identifi  ed positive clones 
kinase for p38) rescued myogenesis (  Puri et al., 2000  ). Cyto-
kines and various types of cellular stress are activators of the 
p38   /    and other pathways (  Zarubin and Han, 2005  ); however, 
treatment of RD cells with TNF    , sorbitol or UV light failed to 
rescue differentiation despite activation of p38   /  ,  revealing that 
differentiation- and stress-induced programs are distinct (  Puri 
et al., 2000  ). Furthermore, the p38   /    pathway functions as a 
switch in muscle satellite cells, required initially to phosphory-
late unidentifi  ed substrates that activate cell cycle entry and sub-
sequently targeting substrates named in the previous paragraph 
to promote cell differentiation (  Jones et al., 2005  ). Presumably, 
these distinct roles of p38   /    signaling require appropriate con-
centrations of p38   /    to become activated at specifi  c times and 
subcellular locations. However, the spatiotemporal regulatory 
mechanisms by which reiteratively used signaling pathways 
(like p38   /   ) achieve such specifi  city are, in most cases, unclear. 
  The Rho family of small GTPases regulates many biologi-
cal processes, including cytoskeletal dynamics, cell polarity, 
signal transduction, and transcription (  Van Aelst and D  ’  Souza-
Schorey, 1997  ;   Jaffe and Hall, 2005  ). They are therefore well 
positioned to coordinate the changes in both gene expression 
and cell morphology that characterize cell differentiation. The 
role in vertebrate myogenesis of one such GTPase, Cdc42, is 
controversial. The concentration of active GTP-bound Cdc42 is 
relatively low in proliferating myoblasts and increases several-
fold in differentiating cells (  Travaglione et al., 2005  ). Studies in 
which constitutively active and dominant-negative mutants of 
  Figure 1.       Cdo interacts with Bnip-2.   (A) Yeast transformed with the indi-
cated vectors for Gal4 DNA binding domain (BD) fused to the transmem-
brane (TM) plus intracellular regions (ICR) of Cdo or Necl-2 and Gal4 
activation domain (AD) fused to Bnip-2 or Pals2 were plated on two-hybrid 
interaction-dependent selective medium. (B) Lysates of 293T cells tran-
siently transfected with ﬂ  ag-tagged Bnip-2, Cdo, or control (    ) expression 
vectors as indicated were immunoprecipitated (IP) with ﬂ  ag antibodies and 
then Western blotted with ﬂ  ag or Cdo antibodies. (C) Lysates of C2C12 
cells cultured in GM to     80% conﬂ  uence and then transferred to DM 
for the indicated times were subjected to Western blot analysis with the 
indicated antibodies. (D) Lysates of C2C12 cells that were proliferating 
in GM (G) or transferred to DM for the indicated times were immuno-
precipitated with Bnip-2 antibodies and then Western blotted with Cdo or 
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actions (  Fig. 2 A  ;   Low et al., 2000b  ;   Zhou et al., 2005  ), was 
tested in an analogous manner. The deletion constructs    261 –
 269,    264 – 284,  and    285 – 292  each  strongly  diminished,  but 
did not fully prevent, Cdo binding (  Fig. 2 C  ). In contrast,    217 –
 221,    235 – 239,  and    251 – 263  bound  Cdo  normally,  suggest-
ing that a 31-aa region (261  –  292) near the C terminus of Bnip-2 
encompasses the site of Cdo binding. 
  Bnip-2 positively regulates myogenic 
differentiation 
  To explore a role for Bnip-2 in myogenesis, C2C12 cells with 
enhanced or diminished Bnip-2 levels were constructed by sta-
ble expression of a   Bnip-2   cDNA or   Bnip-2   siRNAs,  respec-
tively. Forced expression of a   Bnip-2   cDNA  generally  increased 
overall immunoreactivity of Bnip-2 bands about fourfold (  Fig. 
3 A  ). Overexpression of Bnip-2 did not signifi  cantly alter the 
morphology or proliferation of C2C12 cells cultured in GM 
(unpublished data). However, when triggered to differentiate, 
cells that overexpressed Bnip-2 (C2C12/Bnip-2 cells) displayed 
a greater fraction of cell nuclei in myosin heavy chain  –  positive 
(MHC 
+  ) myotubes than did vector control cells (  Fig. 3, B and C  ). 
Furthermore, some of the myotubes formed by C2C12/Bnip-2 
cells had much larger numbers of nuclei than were observed 
with the vector control cells (  Fig. 3 C  , arrow). When analyzed 
for DM-induced expression of muscle-specifi  c proteins, C2C12/
Bnip-2 cells showed accelerated and enhanced levels of the dif-
ferentiation markers myogenin, MHC, and troponin T relative 
to the control cultures (  Fig. 3 A  ). 
  To assess the effects of diminished Bnip-2 levels on dif-
ferentiation, three independent   Bnip-2   sequences placed into 
the pSilencer siRNA vector were individually and stably expressed 
in C2C12 cells. Each sequence substantially reduced Bnip-2 
protein levels (  Fig. 4 A  ). Note that the most slowly migrating 
band was more variably affected than the faster migrating forms 
in   Fig. 4 A   and in later fi  gures. This could represent a more 
encoding Bnip-2 (  Fig. 1 A  ). The intracellular region of another 
Ig protein, Necl-2, did not interact as effi  ciently with Bnip-2, 
nor did Cdo interact as effi  ciently with a Necl-2 binding protein, 
Pals-2 (  Shingai et al., 2003  ;   Takaesu et al., 2006  ). Consistent 
with their interaction in yeast, Cdo and fl   ag  epitope – tagged 
Bnip-2 coimmunoprecipitated when transiently expressed in 
293T cells (  Fig. 1 A  ). Like Cdo, Bnip-2 is expressed endoge-
nously in C2C12 myoblasts, and Bnip-2 levels increased during 
a 4-d time course of differentiation (  Fig. 1 C  ). On SDS-PAGE 
of C2C12 cell lysates, Bnip-2 migrated as a series of bands (  Fig. 
1, C and D  ) that likely represent alternatively spliced variously 
phosphorylated isoforms (  Low et al., 1999  ; unpublished data). 
To assess whether endogenous Cdo and Bnip-2 interact, C2C12 
cells were harvested while proliferating in growth medium (GM) 
or over a 3-d time course after transfer to differentiation me-
dium (DM). Cell lysates were immunoprecipitated with Bnip-2 
antibodies and probed with Cdo antibodies (  Fig. 1 D  ). Cdo co-
precipitated with Bnip-2, with maximal interaction occurring 
over the fi  rst 2 d in DM, which is similar to Cdo  ’  s interaction 
with JLP (  Takaesu et al., 2006  ). 
  To identify the Cdo binding site in Bnip-2, a series of previ-
ously characterized fl  ag-tagged Bnip-2 deletion mutants (  Fig. 2 A  ; 
  Low et al., 2000b  ;   Zhou et al., 2005  ) were tested for their ability 
to coimmunoprecipitate Cdo in transiently transfected COS7 
cells (  Fig. 2 B  ). A construct comprising only the Bnip-2 BCH 
domain (aa 167  –  314) was as effective as full-length Bnip-2 in 
coprecipitating Cdo, but a construct lacking this domain failed 
to do so. Therefore, Bnip-2 binds to Cdo via its BCH domain. 
Boc is a protein that forms cis complexes with Cdo. Their re-
spective ectodomains have strong sequence similarity but their 
intracellular regions are unrelated (  Kang et al., 2002  ). Boc also 
coimmunoprecipitated with Bnip-2, but the interaction appeared 
less effi  cient and was only observed with full-length Bnip-2 
(  Fig. 2 B  ). A series of Bnip-2 mutants with small deletions in 
the BCH domain, which disrupt specifi   c  protein – protein  inter-
  Figure 2.       Cdo binds the BCH domain of 
Bnip-2.   (A) Schematic of Bnip-2 and Bnip-2 
deletion mutants and their ability to bind Cdc-
42GAP and Cdc42 (summarized from   Low 
et al., 2000b  ;   Zhou et al., 2005  ). Note that 
    217  –  221 and     235  –  239 are also known as 
    M and     R, respectively (  Low et al., 2000b  ; 
  Zhou et al., 2005  ). (B) Lysates of COS7 cells 
transiently transfected with ﬂ  ag-tagged  Bnip-2, 
ﬂ  ag-tagged BCH, ﬂ  ag-tagged     BCH, Cdo, myc-
tagged Boc, or control (    ) expression vectors 
as indicated were immunoprecipitated (IP) 
with ﬂ  ag epitope antibodies and then West-
ern blotted with ﬂ   ag epitope, Cdo, or myc 
epitope antibodies. (C) Lysates of COS7 cells 
transiently transfected with ﬂ  ag-tagged Bnip-2, 
ﬂ  ag-tagged Bnip-2 deletion mutants, Cdo, or 
control (    ) expression vectors as indicated 
were immunoprecipitated (IP) with ﬂ  ag epitope 
antibodies and then Western blotted with ﬂ  ag 
epitope or Cdo antibodies. For unknown rea-
sons, a faster migrating Cdo degradation band 
is reproducibly seen when Cdo is coexpressed 
with the     217  –  221 mutant. Lower levels of this 
band are also seen when Cdo is coexpressed 
with the     251  –  263 and     261  –  269 mutants.     JCB • VOLUME 182 • NUMBER 3 • 2008  500
Transfection effi  ciencies of     10% were used to minimize fu-
sion of independent    -gal 
+   transfectants. 48 h after transfection, 
the cultures were transferred to DM, and 72 h later the cells 
were double-stained for     -gal activity and for MHC expression. 
Note that when transfectants fused with nontransfected cells, 
many (often most) of the nuclei in the myotube became positive 
for     -gal activity because the cytoplasmically translated protein 
diffuses within the myotube (  Kang et al., 2004  ;   Takaesu et al., 
2006 ). Expression of wild-type Bnip-2 stimulated MHC expression 
and production of multinucleated myotubes by    -gal 
+   transfec-
tants (  Fig. 5, A and B  ). The    217 – 221  mutant  functioned  similarly 
to wild-type Bnip-2, indicating that interaction with Cdc42GAP 
is not required for Bnip-2  ’  s promyogenic activity. In contrast, 
the    264 – 284  and     285  –  292 mutants lost the ability to pro-
mote myogenesis, suggesting that interaction with Cdc42 and/
or Cdo are required for this activity (  Fig. 5, A and B  ). 
  Cdo and Bnip-2 promote Cdc42 activity, 
and Cdc42 promotes myogenesis 
  The concentration of GTP-bound (active) Cdc42 rises, and is 
maintained, when C2C12 cells are transferred into DM (  Fig. 6 A  ; 
  Travaglione et al., 2005  ). We therefore tested whether modula-
tion of Bnip-2 levels altered the amount of active Cdc42 in these 
cells. C2C12/Bnip-2 cells displayed elevated levels of GTP-
bound Cdc42 relative to vector control cells in both GM and 
DM ( Fig. 6 B ), whereas stable expression of  Bnip-2  siRNA largely 
prevented the DM-induced increase in GTP-bound Cdc42 
( Fig.  6  C ).  The concentration of active Cdc42 therefore corre-
lates with Bnip-2 protein levels. 
  Because Cdo binds Bnip-2 and Bnip-2 binds Cdc42, we 
asked whether Cdc42 was present in Cdo immunoprecipitates 
from differentiating C2C12 cell lysates. Indeed, Cdc42 coprecipi-
tated with Cdo with a maximal interaction 1 d after transfer of cul-
tures to DM (  Fig. 6 D  ). This is similar to Cdo  ’  s interaction with 
Bnip-2 and suggests that formation of a Cdo  –  Bnip-2  –  Cdc42 
complex promotes Cdc42 activation. To test this possibility fur-
ther, C2C12 cells that express   Cdo   siRNA and cultured   Cdo 
   /      
myoblasts were analyzed for Cdc42 activity. In C2C12 cells that 
express   Cdo   siRNA, the DM-associated elevation in GTP-bound 
Cdc42 levels seen in control transfectants was almost completely 
blunted (  Fig. 6 E  ). Primary myoblasts must be cultured in GM 
plus basic FGF to remain in a proliferative nondifferentiated state, 
and both   Cdo 
+/+     and   Cdo 
   /       myoblasts had abundant GTP-bound 
Cdc42 in this medium, likely because of the added growth factor; 
however, when transferred to DM, the   Cdo 
   /       cells had a lower 
concentration of active Cdc42 than did the   Cdo 
+/+     cells (  Fig. 6 F  ). 
  Both Cdo and Bnip-2 positively regulate myogenic dif-
ferentiation and promote activation of Cdc42, suggesting that 
Cdc42 is itself promyogenic. However, previous studies in 
which constitutively active and dominant-negative mutants of 
Cdc42 were expressed in myoblasts failed to provide evidence 
for this notion, as both mutants blocked differentiation (  Meriane 
et al., 2000  ). Expression of siRNA against   Cdc42   in  C2C12 
cells also inhibited differentiation, but these cells acquired a 
strongly altered morphology (unpublished data). Therefore, to 
gain information on the role of Cdc42 in myogenesis, we sought 
to alter Cdc42 activity in a more subtle manner. It was reasoned 
 stable species of Bnip-2 that is relatively resistant to RNAi-mediated 
knockdown or revelation of a protein nonspecifi  cally recognized 
by the Bnip-2 antibody that comigrates with the top Bnip-2 
band. C2C12 cells that expressed each siRNA sequence dis-
played a smaller percentage of cell nuclei in MHC 
+   myotubes, 
and the myotubes that formed were shorter and thinner, than 
control cells that expressed an irrelevant siRNA sequence (  Fig. 4, 
B and C  ). Expression of MHC was delayed and reduced in 
  Bnip-2   siRNA-expressing cells, whereas expression of myogenin 
was not substantially altered, perhaps because of incomplete 
knockdown of Bnip-2 (  Fig. 4 D  ). These latter results suggest 
that myotube formation may be more sensitive to partial loss of 
Bnip-2 than is expression of muscle-specifi  c proteins. 
  Bnip-2 binds to Cdc42, Cdc42GAP, and, as is shown here, 
Cdo. The Bnip-2 deletion mutant    217 – 221  is  selectively  de-
fective in Cdc42GAP binding. The    285 – 292  mutant  does  not 
bind to Cdc42 and is ineffi  cient at binding Cdo but binds Cdc-
42GAP. The    264 – 284  mutant  is  ineffi  cient at binding Cdo but 
interacts normally with Cdc42 and Cdc42GAP (  Fig. 2, A and C  ; 
  Low et al., 2000b  ;   Zhou et al., 2005  ). The ability of these mu-
tants to promote myotube formation was examined in a tran-
sient myogenesis assay that scores expression of MHC and 
myotube formation by transfectants (  Kang et al., 2004  ;   Takaesu 
et al., 2006  ). C2C12 cells were cotransfected with control or 
Bnip-2 expression vectors plus, to mark transfectants, a vector 
that drives expression of nuclear-localized    -galactosidase  (  -gal). 
  Figure 3.       Overexpression of Bnip-2 enhances myogenic differentiation.   
(A) Lysates of C2C12 cells stably transfected with a control expression vec-
tor lacking a cDNA (    ) or with an expression vector harboring a   Bnip-2   
cDNA (+) were Western blotted with antibodies to Bnip-2, the indicated 
muscle-speciﬁ  c proteins, or Cdo and, as a control, with pan-cadherin anti-
body. (B) Photomicrographs of C2C12/Bnip-2 and vector control cells 
that were cultured in DM, ﬁ  xed, and stained with an antibody to MHC. 
The arrow indicates a C2C12/Bnip-2 cell myotube with many more nuclei 
than are seen with the control cells under these conditions. Bar, 0.1 mm. 
(C) Quantiﬁ  cation of myotube formation. Values represent means of tripli-
cate determinations   ±  1 SD. The experiment was repeated three times with 
similar results. Asterisks indicate difference from control, P   <   0.01. A level 
of myotube formation by control cells (    35% nuclei in MHC 
+   cells) was se-
lected so as to permit visualization of enhanced differentiation by Bnip-2.     501 CDO  –  BNIP-2  –  CDC42 SIGNALING IN MYOGENESIS   • Kang et al. 
  To enhance Cdc42 activity, three independent siRNA se-
quences against  Cdc42GAP  were stably expressed in C2C12 cells. 
Two of these sequences effectively diminished Cdc42GAP pro-
tein levels, and this was associated with an increase in the amount 
of GTP-bound Cdc42 in these cells (  Fig. 8, A and B  ). When cul-
tured in DM, cells with diminished levels of Cdc42GAP produced 
larger myotubes (  Fig. 8 C  ), had a higher percentage of nuclei pre-
sent in MHC 
+   cells (  Fig. 8 D  ), and expressed more MHC protein 
than did control transfectants (  Fig. 8 E  ). Collectively, the results 
indicate that Cdc42 activity promotes myogenesis. 
  Cdo brings JLP and Bnip-2 together to 
regulate p38    /     activity 
  Cdc42 signaling activates p38   /    MAPK in several cell sys-
tems (  Coso et al., 1995  ;   Minden et al., 1995  ;   Moln  á  r et al., 
that the concentration of GTP-bound Cdc42 and, perhaps more 
importantly, the amount of time Cdc42 proteins spend in the 
active state could be altered by modulating the amount of Cdc-
42GAP protein expressed by C2C12 cells. Two GAP proteins 
for Cdc42, Cdc42GAP and BPGAP (  Shang et al., 2003  ), were 
each stably overexpressed in C2C12 cells (  Fig. 7 A  ). In both 
cases, this resulted in lower steady-state levels of GTP-bound 
Cdc42 in both GM and DM, relative to control vector transfec-
tants (  Fig. 7 B  ). When cultured in DM, C2C12/Cdc42GAP cells 
and C2C12/BPGAP cells each displayed a similar phenotype: 
relative to control cells, a smaller percentage of cell nuclei were 
found in MHC 
+   myotubes, and the myotubes that formed were 
shorter and thinner (  Fig. 7, C and D  ). Furthermore, overexpres-
sion of Cdc42GAP or BPGAP resulted in delayed induction of 
the differentiation markers myogenin and MHC (  Fig. 7 E  ). 
  Figure 4.       RNAi-mediated depletion of Bnip-2 
reduces myogenic differentiation.   (A) Lysates 
of C2C12 cells stably transfected with pSi-
lencer containing one of three independent 
  Bnip-2   siRNA sequences (designated 1, 3, 
and 4) or pSilencer containing an irrelevant 
sequence (    ) were Western blotted with Bnip-2 
or, as a control, pan-cadherin antibodies. 
(B) Photomicrographs of C2C12 cells that ex-
press   Bnip-2   siRNA sequences or an irrelevant 
sequence (pSilencer) as indicated, cultured in 
DM, ﬁ   xed, and stained with an antibody to 
MHC. Bar, 0.5 mm. (C) Quantiﬁ  cation of myo-
tube formation. Values represent means of trip-
licate determinations   ±  1 SD. The experiment 
was repeated three times with similar results. 
Asterisks indicate difference from pSilencer 
control, P   <   0.01. A level of myotube forma-
tion by control cells (    80% nuclei in MHC 
+   
cells) was selected so as to permit visualization 
of diminished differentiation by   Bnip-2   siRNA. 
(D) Western blot analysis of C2C12 cells that 
express   Bnip-2   siRNA sequences (+) or an ir-
relevant sequence (    ) cultured in GM (G) or in 
DM for the indicated times.     
  Figure 5.       Bnip-2 deletion mutants defective in 
binding Cdc42 and Cdo do not promote myo-
genic differentiation.   (A) C2C12 cells were 
cotransfected with control, Bnip-2 or Bnip-2 de-
letion mutant expression vectors, and pQ-lacZ 
(a vector that drives expression of nuclear-local-
ized     -gal to mark transfectants). Differentiated 
cultures were double stained for     -gal activity 
(blue) and for MHC expression (brown). Bar, 
0.1 mm. (B) Quantiﬁ  cation of C2C12 cell dif-
ferentiation shown in A. Cultures were scored 
as MHC 
      or MHC 
+  , with MHC 
+   cells further 
scored as having a single (1) nucleus, two to 
four nuclei, or greater than or equal to ﬁ  ve 
nuclei. Values represent means of triplicate 
determinations   ±  1 SD. The experiment was 
repeated three times with similar results.     JCB • VOLUME 182 • NUMBER 3 • 2008  502
between two and fi  ve nuclei (    45%), and those that had greater 
than fi  ve nuclei (  <  5%;   Fig. 9, G and H  ). The expression of   Bnip-2  
siRNA decreased the percentage of MHC 
+   cells to    66%,  with 
multinucleated cells representing only     16%, none of which 
were in the greater-than-fi  ve-nuclei category. Therefore, tran-
sient expression of   Bnip-2   siRNA reduced myogenesis, which is 
similar to stable knockdown of Bnip-2. Expression of MKK6(EE) 
alone enhanced myogenesis relative to control transfectants, re-
sulting in    94%  MHC 
+   cells, with     30% of the total having 
greater than fi  ve nuclei. Cells that coexpressed MKK6(EE) and 
  Bnip-2   siRNA underwent robust myogenesis, though not quite 
to the level observed with expression of MKK6(EE) alone 
(   95%  MHC 
+   cells, but only     15% with greater than fi  ve nu-
clei). These results are consistent with the notion that Bnip-2  ’  s 
promyogenic function is exerted mainly, though perhaps not ex-
clusively, via activation of p38   /  . 
  We also assessed the effects of MKK6(EE) expression on 
cells that coexpressed the Bnip-2 deletion mutants    264 – 284 
and   285 – 292. Similar to the results shown in  Fig. 5 , expression 
of either of these two mutants did not dramatically alter myo-
genesis relative to control transfectants, suggesting a loss of 
function (  Fig. 9, G and H  ). Coexpression of MKK6(EE) en-
hanced differentiation of cells expressing these mutants, but the 
effect was seen more in the production of multinucleated MHC 
+  
cells, with a smaller effect on the percentage of MHC 
+   versus 
MHC 
      cells. The results with the deletion mutants plus or mi-
nus MKK6(EE) are somewhat distinct from the effects seen 
with   Bnip-2   siRNA plus or minus MKK6(EE) and suggest that 
these mutants may have a subtle inhibitory effect made apparent 
by coexpression of MKK6(EE). 
  Cdo/Bnip-2 signaling does not account 
for all p38    /     activity in differentiating 
myoblasts, and other p38    /    -activating 
stimuli function in its absence 
  C2C12 cells that express siRNA against   Bnip-2   or   Cdo ,  and 
  Cdo 
   /       myoblasts, each display a partially defective differentia-
tion program accompanied by lower than normal levels of DM-
induced pp38   /    (  Takaesu et al., 2006  ; this study). However, 
1997  ;   Bourdoulous et al., 1998  ). The ability of Cdo to bind 
Bnip-2 and JLP, which in turn bind Cdc42 and p38   /  ,  respec-
tively, suggests that Cdo might coordinate Cdc42  → p38  /    sig-
naling. The possibility that Bnip-2 and JLP bind the same Cdo 
complexes was tested initially. COS7 cells were transfected 
with expression vectors encoding S epitope  –  tagged JLP (JLP-S), 
JLP-S and Bnip-2, or JLP-S, Bnip-2, and Cdo. Cell lysates were 
then precipitated with anti  –  S agarose and blotted with anti-
bodies to each protein (  Fig. 9 A  ). JLP coprecipitated Bnip-2 in 
the presence, but not the absence, of coexpressed Cdo. There-
fore, JLP and Bnip-2 did not directly interact but were brought 
together by a mutual interaction with Cdo. To assess whether 
such complexes form endogenously, lysates of   Cdo 
+/+     and   Cdo 
   /      
myoblasts were immunoprecipitated with antibodies to Cdo or 
to Bnip-2 and then Western blotted with antibodies to Cdo, 
Bnip-2, and JLP. As expected, Bnip-2 and JLP both coprecipi-
tated with Cdo (  Fig. 9 B  ;   Takaesu et al., 2006  ). Furthermore, 
JLP coprecipitated with Bnip-2 from   Cdo 
+/+     cell lysates but not 
  Cdo 
   /       cell lysates, indicating that Bnip-2 and JLP associate in 
myoblasts in a Cdo-dependent manner (  Fig. 9 C  ). 
  C2C12/Bnip-2 cells, which had elevated Cdc42 activity in 
GM and DM (  Fig. 6  ), also had elevated levels of the dually 
phosphorylated (active) form of p38   /    (pp38  /   ) in GM and 
DM (  Fig. 9 D  ). Conversely, C2C12 cells that stably express 
  Bnip-2   siRNA, which poorly activated Cdc42 in response to 
DM (  Fig. 6  ), were also defi  cient in DM-induced pp38   /    pro-
duction ( Fig. 9 E ). Furthermore, expression of  Cdc42GAP  siRNA 
increased pp38   /    levels in C2C12 cells in both GM and DM 
(  Fig. 9 F  ). Collectively, these results are consistent with a model 
in which Cdo brings Bnip-2 and JLP together to coordinate 
Cdc42  → p38  /    signaling. 
  To assess whether p38   /    is functionally downstream of 
Bnip-2, we asked whether coexpression of the p38   /    activator 
MKK6(EE) could rescue the differentiation defect associated 
with expression of   Bnip-2   siRNA. The transient C2C12 cell 
myogenesis assay described earlier (  Fig. 5  ) was used in this 
case. Approximately     83% of double control-vector transfec-
tants were MHC 
+  , and these cells were categorized as those that 
were mononucleated (    35% of total cell nuclei), those that had 
  Figure 6.       Bnip-2 and Cdo regulate Cdc42 
activity.   (A) GTP-bound Cdc42 (Cdc42*) in 
C2C12 cells proliferating in GM (G) or cul-
tured for 48 h in DM (D) was pulled down from 
cell lysates with GST-PAK-1 PBD beads and 
Western blotted with Cdc42 antibodies (top). 
Total levels of Cdc42 were determined by blot-
ting straight lysates with Cdc42 antibodies 
(bottom). (B) Levels of GTP-bound and total 
Cdc42 in C2C12/Bnip-2 (+) or vector control 
(    ) cells in GM or DM were assessed as de-
scribed in A. (C) Levels of GTP-bound and to-
tal Cdc42 in C2C12 cells that express   Bnip-2   
siRNA (+) or an irrelevant sequence (    ) in GM 
or DM were assessed as described in A. (D) Ly-
sates of C2C12 cells cultured in GM to     80% 
conﬂ  uence and then transferred to DM for the 
indicated times were immunoprecipitated with 
Cdo antibodies and then Western blotted with 
Cdc42 or Cdo antibodies. (E) Levels of GTP-bound and total Cdc42 in C2C12 cells that express   Cdo   siRNA (+) or an irrelevant sequence (    ) in GM or 
DM were assessed as described in A. The arrowhead indicates a nonspeciﬁ  c band. (F) Levels of GTP-bound and total Cdc42 in myoblasts of the indicated 
  Cdo   genotype cultured in GM or DM assessed as described in A.     503 CDO  –  BNIP-2  –  CDC42 SIGNALING IN MYOGENESIS   • Kang et al. 
express no Cdo protein, are also MHC 
+   (  Takaesu et al., 2006  ). 
These results suggest that other pathways that activate p38   /   
are functional in Cdo- and Bnip-2  –  depleted myoblasts. 
  To assess directly whether additional stimuli can activate 
p38   /    in cells depleted of Cdo or Bnip-2,   Cdo 
   /       myoblasts 
and C2C12 cells expressing   Cdo   or   Bnip-2   siRNA were treated 
with TNF     or with hyperosmotic stress and analyzed for pro-
duction of pp38   /   . Such cells produced pp38   /    at levels 
similar to those of control cells in response to these stimuli 
(  Fig. 10, D  –  F  ). Collectively, the results suggest that Cdo/Bnip-2 
signaling is neither the sole mechanism by which p38   /    be-
comes activated during myogenesis nor a general requirement 
for full p38   /    activation but is likely to be specifi  c for differ-
entiation-mediated signaling. 
  Discussion 
  Many ubiquitous signaling pathways perform cell type  –  specifi  c 
functions. Furthermore, such pathways can regulate disparate 
functions in the same cell type. Clearly, this requires that the 
myoblasts cultured in the presence of the p38   /    inhibitor 
SB203580 have a more dramatic blockade to differentiation 
(  Cuenda and Cohen, 1999  ;   Zetser et al., 1999  ;   Wu et al., 2000  ). 
It seems likely, therefore, that Cdo/Bnip-2 – independent pathways 
also contribute to p38   /    activation during myogenesis. To ex-
amine this point more closely, C2C12 cells that stably express 
  Bnip-2   or   Cdo   siRNA were treated with SB203580 and assessed 
for myotube formation and expression of MHC (  Fig. 10, A  –  C  ). 
The percentages of control cell nuclei that were present in MHC 
+  
versus MHC 
      cells was     80:20, whereas this MHC 
+ /MHC 
      ratio 
was   10:90 in SB203580-treated control cells. The MHC 
+ /MHC 
     
ratio of C2C12 cells expressing either   Cdo   or   Bnip-2   siRNA 
was     40:60, which is consistent with incomplete inhibition of 
differentiation. Treatment of such cells with SB203580 further 
reduced the ratio to     10/90, which is similar to that of vector 
control cells. Therefore, the cells with diminished levels of Cdo 
or Bnip-2 that express MHC remain dependent on residual 
p38   /    activity to do so. Although the extent of siRNA-mediated 
depletion is not 100%,     40% of   Cdo 
   /       myoblasts, which 
  Figure 7.       Overexpression of Cdc42GAP or BPGAP reduces myogenic dif-
ferentiation.   (A) Lysates of C2C12 cells stably transfected with a control ex-
pression vector lacking a cDNA (    ) or with expression vectors harboring 
ﬂ  ag-tagged Cdc42GAP or BPGAP cDNAs as indicated (+) were Western 
blotted with ﬂ   ag epitope or Cdc42GAP antibodies. (B) Levels of GTP-
bound and total Cdc42 in C2C12/Cdc42GAP, C2C12/BPGAP, or vector 
control (    ) cells in GM or DM were assessed as described in   Fig. 6 A  . 
(C) Photomicrographs of C2C12/Cdc42GAP, C2C12/BPGAP, and vector 
control cells that were cultured in DM, ﬁ  xed, and stained with an antibody 
to MHC. Bar, 0.1 mm. (D) Quantiﬁ  cation of myotube formation. Values 
represent means of triplicate determinations   ±  1 SD. The experiment was 
repeated three times with similar results. Asterisks indicate difference from 
control, P   <   0.01. A level of myotube formation by control cells (    80% 
nuclei in MHC 
+   cells) was selected so as to permit visualization of dimin-
ished differentiation by Cdc42GAP proteins. (E) Western blot analysis of 
muscle-speciﬁ  c proteins by C2C12 cell transfectants cultured in GM (G) or 
in DM for the indicated times.     
  Figure 8.       RNAi-mediated depletion of Cdc42GAP enhances myogenic 
differentiation.   (A) Lysates of C2C12 cells stably transfected with pSilencer 
containing one of three independent   Cdc42GAP   siRNA sequences (desig-
nated 1, 2, and 3) or pSilencer containing an irrelevant sequence (    ) were 
Western blotted with Cdc42GAP or, as a control, pan-cadherin antibodies. 
(B) Levels of GTP-bound and total Cdc42 in C2C12 cells that express   Cdc-
42GAP   siRNA (+) or an irrelevant sequence (    ) in DM were assessed as 
described in   Fig. 6 A  . (C) Photomicrographs of C2C12 cells that express 
  Cdc42GAP   siRNA sequences or an irrelevant (pSilencer) sequence as in-
dicated, cultured in DM, ﬁ  xed, and stained with an antibody to MHC. Bar, 
0.1 mm. (D) Quantiﬁ  cation of myotube formation. Values represent means 
of triplicate determinations   ±  1 SD. The experiment was repeated three 
times with similar results. Asterisks indicate difference from pSilencer con-
trol, P   <   0.02. A level of myotube formation by control cells (    45% nuclei 
in MHC 
+   cells) was selected so as to permit visualization of enhanced 
differentiation by   Cdc42GAP   siRNA. (E) Western blot analysis of MHC ex-
pression by C2C12 cells that express   Cdc42GAP   siRNA sequences num-
bers 1 or 3 or an irrelevant sequence (    ), cultured in DM for 48 h.     JCB • VOLUME 182 • NUMBER 3 • 2008  504
 Fig. 10 G ). JLP and Bnip-2 associate in a Cdo-dependent manner, 
implying that Cdc42 bound to Cdo via Bnip-2 activates p38   /   
bound to Cdo via JLP and that this represents a pool of p38   /   
specifi  cally activated during differentiation. We speculate that 
binding of Bnip-2  –  Cdc42 to Cdo allows Cdc42 to interact with a 
specifi  c guanine nucleotide exchange factor, promoting nucleo-
tide exchange on Cdc42 and subsequent binding to effector pro-
teins that initiate a kinase cascade resulting in activation of 
p38   /  . Alternatively, Cdc42 may be activated before association 
with Cdo, and subsequent interaction between Cdo, Bnip-2, and 
Cdc42 stabilizes Cdc42 in the active state and brings it into prox-
imity with components of the p38   /    pathway. 
  All the described components of this complex are ubiqui-
tously expressed except Cdo, which, though not muscle specifi  c, 
is highly enriched in muscle precursor cells and differentiating 
muscle (  Kang et al., 1998  ;   Mulieri et al., 2000  ), suggesting that 
Cdo itself may provide some level of cell type specifi  city to this 
signaling pathway. Cdo is also expressed at high levels in neu-
ronal precursors, and similar results to those reported here have 
been obtained in experiments on neuronal differentiation of a 
activation of these pathways occurs at the correct time and sub-
cellular location and with the appropriate magnitude and dura-
tion. The mechanisms by which such specifi  city is achieved 
are not well understood. We previously reported that during 
myogenic differentiation, the cell surface receptor Cdo binds 
the p38   /    pathway scaffold protein JLP and, via JLP, p38   /   
itself (  Takaesu et al., 2006  ).   Cdo 
   /       myoblasts are defi  cient in 
both p38   /    activity and differentiation capability, and their 
ability to differentiate is rescued by expression of the p38   /   
activator MKK6(EE) (  Takaesu et al., 2006  ); however, these re-
sults did not explain how association of JLP/p38   /    with  Cdo 
leads to activation of p38   /  . 
  In this paper, it is demonstrated that Cdo also associates 
with the Cdc42 binding protein Bnip-2, identifying a novel link-
age between a cell surface receptor and downstream modulation 
of Cdc42 activity. This interaction stimulates Cdc42 and p38   /   
activities and regulates myogenic differentiation. Cdo, therefore, 
appears to promote activation of p38   /    by assembly of multi-
protein signaling modules for Cdc42 and p38   /    via direct bind-
ing to scaffold proteins for each (i.e., Bnip-2 and JLP, respectively; 
  Figure 9.       Bnip-2 and JLP bind the same Cdo 
complexes, and Bnip-2 regulates p38    /     ac-
tivity to promote myogenesis.   (A) Lysates of 
COS7 cells transiently transfected with JLP-S, 
Bnip-2, Cdo, or control (    ) expression vectors 
as indicated were immunoprecipitated (IP) with 
anti  –  S agarose and then Western blotted with 
JLP, Bnip-2, or Cdo antibodies. (B) Lysates of 
myoblasts of the indicated   Cdo   genotype cul-
tured in DM for 48 h were immunoprecipitated 
with Cdo antibodies and then Western blotted 
with Cdo, Bnip-2, or JLP antibodies. Total cell 
lysates were also Western blotted with Bnip-2 
or JLP antibodies. (C) Lysates of myoblasts of 
the indicated   Cdo   genotype cultured in DM 
for 48 h were immunoprecipitated with Bnip-2 
antibodies and then Western blotted with 
Cdo, Bnip-2, or JLP antibodies. Total cell ly-
sates were also Western blotted with Cdo or 
JLP antibodies. The Cdo band below the one 
indicated by the arrow is a partial degrada-
tion product. (D) Lysates of C2C12/Bnip-2 
(+) or vector control (    ) cells in GM or cul-
tured for 48 h in DM were Western blotted 
with anti  –  phospho p38    /     (pp38) or p38    /     
(p38) antibodies. (E) Lysates of C2C12 cells 
stably expressing a   Bnip-2   siRNA sequence 
(+) or an irrelevant sequence (    ) in GM or 
cultured for 48 h in DM were Western blot-
ted with pp38 or p38 antibodies. (F) Lysates of 
C2C12 cells stably expressing a   Cdc42Gap   
siRNA sequence (+) or an irrelevant sequence 
(    ) in GM or cultured for 48 h in DM were 
Western blotted with pp38 or p38 antibodies. 
As the lanes were somewhat unevenly loaded 
in F, the pp38 and p38 signals were quantiﬁ  ed 
by densitometry, and the pp38/p38 ratio re-
ported under each lane in arbitrary units with 
the control transfectants in GM set to 1. (G) 
C2C12 cells were cotransfected with control, 
  Bnip-2   siRNA, or Bnip-2 deletion mutant ex-
pression vectors, control or MKK6(EE) expres-
sion vectors, and pQ-lacZ (a vector that drives 
expression of nuclear-localized     -gal to mark transfectants). Differentiated cultures were double-stained for     -gal activity (blue) and for MHC expression 
(brown). Bar, 0.1 mm. (H) Quantiﬁ  cation of C2C12 cell differentiation shown in G. Cultures were scored as MHC 
      or MHC 
+  , with MHC 
+   cells further 
scored as having a single (1) nucleus, two to ﬁ  ve nuclei, or greater than ﬁ  ve nuclei. Values represent means of triplicate determinations   ±  1 SD. The experi-
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Active cycling of Cdc42 may be required for effi  cient myo-
genesis, as the results presented in this paper demonstrate that 
Cdc42 activity is important for this process, but expression of 
constitutively active or dominant-negative mutants of Cdc42 
each block differentiation (  Meriane et al., 2000  ). The ability of 
Cdc42 to trigger p38   /    activation  fi  ts well with the known 
importance of p38   /    in myogenic differentiation (  Lluis et al., 
2006  ). However, Cdc42 regulates additional processes that are 
also likely to be relevant to differentiation, such as the forma-
tion of fi  lopodia, which may be required for cell  –  cell inter-
actions in preparation for fusion, and regulation of cell polarity 
(  Jaffe and Hall, 2005  ). That forced expression of the p38   /   
activator MKK6(EE) has a somewhat greater effect on differen-
tiation of control myoblasts than on myoblasts depleted of 
Bnip-2 is consistent with the notion that promyogenic pathways 
other than p38   /    lie downstream of Cdc42, but additional 
work will be required to establish that this is the case. 
neural precursor line (unpublished observations). It is also clear, 
however, that not all p38   /    pathway activity during myoblast 
differentiation is Cdo- or Bnip-2  –  dependent, as residual pp38   /    
is detected in cells depleted for Cdo or Bnip-2, and treatment of 
such cells with the p38   /    inhibitor SB203580 further inhibits 
their differentiation. Potential additional mechanisms for activation 
of p38   /    in differentiating myoblasts include low-level auto-
crine TNF     signaling and signaling by semaphorin 4C (  Ko et al., 
2005  ;   Chen et al., 2007  ;   Riuzzi et al., 2007  ;   Wu et al., 2007  ). 
  In addition to binding Cdc42, Bnip-2 binds its negative 
regulator, Cdc42GAP (  Low et al., 1999  ). However, loss- and 
gain-of-function experiments in myoblasts indicate that Bnip-2 
stimulates Cdc42 activity. These data suggest that Bnip-2 may 
function as a scaffold for dynamic signaling through Cdc42, 
modulating the balance or kinetics of its activity cycle. This is 
the fi  rst paper to fi  nd an endogenous function for Bnip-2, and we 
are unaware of another protein with this type of activity for Cdc42. 
  Figure 10.       Other mechanisms of p38    /     ac-
tivation occur in the absence Cdo/Bnip-2 sig-
naling.   (A) Photomicrographs of C2C12 cells 
stably transfected with control vector or vectors 
expressing   Cdo   or   Bnip-2   siRNA that were cul-
tured in DM plus SB203580 (+SB) or DMSO 
vehicle (    SB), ﬁ  xed, and stained with an anti-
body to MHC. Bar, 0.1 mm. (B) Quantiﬁ  cation 
of the percentage of nuclei in cultures shown in 
A that were in MHC 
+   or MHC 
      cells. Control 
vector cells are indicated by the negative sign 
for both   Cdo   and   Bnip-2   siRNA. Values repre-
sent means of triplicate determinations   ±  1 SD. 
The experiment was repeated three times with 
similar results. Asterisks indicate difference 
from vector control, P   <   0.01. (C) Western 
blot analysis of cultures shown in A. Extracts 
were probed with antibodies to MHC or total 
p38    /     (p38). (D) Myoblasts of the indicated 
  Cdo   genotype were treated with 0.9 M NaCl 
or 10 ng/ml TNF     for 15 min and analyzed 
for pp38    /     and p38    /    . (E) C2C12 cells 
stably expressing siRNA against   Cdo   were 
treated with NaCl or TNF     and analyzed 
as in D. (F) C2C12 cells stably expressing 
siRNA against   Bnip-2   were treated with NaCl 
or TNF     and analyzed as in D. (G) Model of 
Cdo-mediated p38    /     activation during myo-
genic differentiation. Cdo binds directly to JLP 
and, via JLP, to p38    /    . Cdo also binds to 
Bnip-2 and, via Bnip-2, Cdc42. Formation of 
a Cdo  –  Bnip-2  –  Cdc42 complex promotes or 
stabilizes activation of Cdc42, which in turn 
triggers signals culminating in phosphorylation 
and activation of p38    /     bound to Cdo via 
JLP. Cdo interacts with itself (  Kang et al., 2003  ) 
and is shown as a dimer. JLP and Bnip-2 are 
shown as binding to different Cdo proteins of 
the dimer for convenience and does not pre-
clude the possibility that JLP and Bnip-2 bind 
the same Cdo protein simultaneously. See text 
for additional details.     JCB • VOLUME 182 • NUMBER 3 • 2008  506
2.1-U6 hygro vector harboring an irrelevant sequence (Ambion) was used 
as a control. These vectors were transfected into C2C12 cells with Fu-
Gene6 and cultures were selected in hygromycin-containing medium. 
Drug-resistant cells were pooled and analyzed. Multiple such pools were 
studied in each case. 
  Where indicated,   Cdo 
+/+     and   Cdo 
    /        myoblasts and C2C12 cell 
derivatives were treated with 10 ng/ml TNF     (Sigma-Aldrich) or 0.9 M 
NaCl for 15 min. C2C12 cell derivatives were treated with 2.5   μ  M 
SB203580 (EMD) in DM, replenished every 12 h, and harvested after 
48 h for analysis. 
  For Cdo  –  Bnip-2 interaction studies, expression vectors encoding 
Cdo, myc-tagged Boc, Bnip-2, and Bnip-2 deletion mutants (  Low et al., 
2000b  ;   Kang et al., 2002  ;   Zhou et al., 2005  ) were transiently transfected 
into COS7 or 293T cells with FuGene6 or calcium phosphate, respectively. 
48 h later, cells were harvested for Western blot and immunoprecipitation 
analyses as described in the next section. 
  Western blot, immunoprecipitation, and Cdc42 activity analyses 
  Western blot analyses were performed as previously described (  Kang et al., 
2004  ). For immunoprecipitations, cells were lysed in extraction buffer (20 mM 
Hepes, pH 7.5, 150 mM NaCl, 1.5 mM MgCl  2  , 10 mM NaF, 2 mM DTT, 
1 mM Na  3  VO  4  , and 0.5% Triton X-100 supplemented with one tablet/
40 ml of Complete protease inhibitor cocktail [Roche]). 1 mg of whole cell 
extract from each sample was precleared with protein G  –  Sepharose (GE 
Healthcare) conjugated with 1   μ  g of normal rabbit IgG (Santa Cruz Bio-
technology, Inc.) for 1 h at 4  °  C, followed by immunoprecipitation with 
1   μ  g of Cdo, ﬂ  ag epitope, or Bnip-2 antibodies for 2 h at 4  °  C. Immuno-
complexes were washed three times with, and suspended in, extraction 
buffer, and samples were analyzed by Western blotting. For S-agarose 
pulldown experiments, whole cell extracts were incubated with 20   μ  l of 
50% slurry S-protein agarose beads (EMD) for 3.5 h at 4  °  C. Beads were 
washed three times with, and suspended in, extraction buffer, and samples 
were analyzed by Western blotting. Levels of GTP-bound Cdc42 were ana-
lyzed with the Cdc42 Activation Assay kit with PAK-1 PBD-agarose (Millipore), 
according to the manufacturer  ’  s instructions. 
  Antibodies used were the following: anti-Cdo (Invitrogen), anti-
p38    /     (Sigma-Aldrich), anti-pp38    /     (Cell Signaling Technology), anti  –
  S-probe (Santa Cruz Biotechnology, Inc.), anti-MHC (MF-20; Developmental 
Studies Hybridoma Bank), anti-TnT (Sigma-Aldrich), anti-myogenin (Santa 
Cruz Biotechnology, Inc.), anti-Cdc42 (Millipore), anti-Cdc42GAP (Abnova), 
anti  –  Bnip-2 (  Low et al., 1999  ), anti-ﬂ  ag epitope (Sigma-Aldrich), anti  –
  pan-cadherin (Sigma-Aldrich), anti-Boc, and anti-myc (9E10; Mount Sinai 
Hybridoma Core Facility). 
  Microscopy 
  Cultures were ﬁ  xed and processed for MHC expression and/or     -gal activ-
ity as described in the previous sections and examined on a phase contrast 
microscope (Eclipse TS100; Nikon) with Plan Fluor 10  ×  /0.3 NA and 
20  ×  /0.45 NA objectives (Nikon) at room temperature. Images were cap-
tured with a camera (Spot RT Color model 2.2.1; Diagnostic Instruments, 
Inc.) using Spot software (version 3.5.9; Diagnostic Instruments, Inc.) and 
Photoshop 7.0 (Adobe). 
  We thank Reshma Taneja, Jeanne Hirsch, and members of the Krauss laboratory 
for critical reading of the manuscript and David Glass for helpful discussions. 
  This work was supported by grants from the National Institutes of Health 
(AR46207) and the T.J. Martell Foundation to R.S. Krauss, the Samsung Bio-
medical Research Institute (B-A7-002) to J.S. Kang, and the Biomedical Rease-
arch Council Singapore (R154000271305) to B.C. Low. 
Submitted:   18 January 2008 
Accepted:   7 July 2008 
  References 
   Bourdoulous ,   S. ,   G.    Orend ,   D.A.    MacKenna ,   R.    Pasqualini ,  and   E.    Ruoslahti . 
  1998  .   Fibronectin matrix regulates activation of RHO and CDC42 
GTPases and cell cycle progression.       J. Cell Biol.     143 : 267  –  276 .    
   Briata ,   P. ,   S.V.    Forcales ,   M.    Ponassi ,   G.    Corte ,   C.Y.    Chen ,   M.    Karin ,   P.L.    Puri , 
and   R.    Gherzi .   2005 .   p38-dependent  phosphorylation  of  the  mRNA 
  decay-promoting factor KSRP controls the stability of select myogenic 
transcripts.     Mol. Cell   .    20 : 891  –  903 .    
   Chen ,   S.E. ,   B.    Jin ,  and  Y.P.    Li .   2007 .   TNF-alpha  regulates  myogenesis  and  mus-
cle regeneration by activating p38 MAPK.       Am. J. Physiol. Cell Physiol.   
 292 : C1660  –  C1671 .    
  Collectively, these results reveal a distinctive mechanism 
of signaling: the Cdo intracellular region binds to scaffold pro-
teins that in turn bind multiple components of specifi  c path-
ways. This is different from other Ig/FNIII repeat receptors 
related to Cdo, such as the Robo proteins, which bind to the 
nonreceptor tyrosine kinase, c-Abl, the Rho family GAPs srGAP 
and Vilse, the SH2/SH3 adaptor Nck, and the actin regulator Ena/
Vasp (  Dickson and Gilestro, 2006  ). Furthermore, Cdo functions 
in multiple contexts at the extracellular face of the cell surface. 
In myoblasts, it forms cis complexes with N-cadherin and neo-
genin, the latter a receptor for the netrin and RGM families 
of ligands (  Kang et al., 2003  ,   2004  ;   Cole et al., 2007  ). Addition-
ally, Cdo binds Sonic hedgehog, possibly as a coreceptor with 
Patched1 (  Tenzen et al., 2006  ;   Yao et al., 2006  ;   Martinelli and 
Fan, 2007  ). The mechanism by which binding of JLP and Bnip-2 
to Cdo is induced during myogenesis is not clear, but a connec-
tion with N-cadherin is likely. Expression in C2C12 cells of 
a Cdo deletion mutant that is specifi  cally defi  cient in its ability 
to bind N-cadherin blocks differentiation (  Kang et al., 2003  ). 
N-cadherin – based  adhesion  enhances  p38  /    activity in C2 
myoblasts (  Lovett et al., 2006  ), and preliminary results suggest 
that Cdo, JLP, and Bnip-2 can be recruited to sites of N-cadherin 
ligation (unpublished data). Cdo may function to link cadherin-
based adhesion to the p38   /    pathway, which promotes the 
muscle-specifi  c transcriptional program. That Cdc42, a known 
regulator of actin dynamics, is directly involved in this process 
provides a mechanism by which such changes in gene expres-
sion can be coordinated with the alterations in cell morphology 
that are also required for cell differentiation. 
  Materials and methods 
  Yeast two-hybrid screen 
    Bnip-2   was identiﬁ  ed in a previously reported screen in which the trans-
membrane plus intracellular region of mouse Cdo was used as bait 
(  Takaesu et al., 2006  ). Two independent clones were isolated a total of 
eight times. Both clones started in the 5     UTR, were in frame, and encoded 
the entire   Bnip-2   ORF. 
  Cell culture 
  C2C12, 293T, COS7, and myoblasts derived from   Cdo 
+/+     and   Cdo 
    /        
mice were cultured as previously described (  Kang et al., 1998  ,   2004  ; 
  Cole et al., 2004  ). To induce differentiation of C2C12 cells, cultures were 
transferred from DME containing 15% FBS (GM) to DME containing 2% 
horse serum (DM). Myotube formation in stable and transient assays was 
performed and quantiﬁ  ed as previously described (  Kang et al., 2004  ). 
Statistical analysis of the number of nuclei in MHC 
+   versus MHC 
      cells was 
done with Student  ’  s   t   test. 
  For stable overexpression studies in myoblasts, pXJ40 vectors en-
coding ﬂ  ag-tagged forms of Bnip-2, Cdc42GAP, or BPGAP (  Low et al., 
1999  ,   2000a  ,  b  ) were cotransfected with pBabePuro (  Morgenstern and 
Land, 1990  ) into C2C12 cells with FuGene6 (Roche), and cultures were 
selected in puromycin-containing medium. Drug-resistant cells were pooled 
and analyzed. Multiple such pools were studied in each case. 
  For siRNA studies, the following sequences were inserted into pSi-
lencer 2.1-U6 hygro (Ambion):   Bnip-2   #1: 5    -GATCCCGATCAGATACGT-
CTTTAACTTCAAGAGAGTTAAAGACGTATCTGATCGTTTTTTGGAAA-3    ; 
  Bnip-2   #3: 5    -GATCCCGGAAGAATGGCAGGATGAATTCAAGAGATTC-
ATCCTGCCAT TCTTCCGTTTTTTGGAAA-3    ;   Bnip-2   #4: 5    -GATCCCGTG-
GTGCGACAACTCGAAGATTCAAGAGATCTTCGAGTTGTCGCACCAC-
GTTTTTTGGAAA-3    ;   Cdc42GAP   #1: 5    -GATCCCGGCCAAGCTCTGAAC-
CAGTTTTCAAGAGAAACTGGTTCAGAGCTTGGCTTTTTTGGAAA-3    ; and 
  Cdc42GAP   #3: 5    -GATCCCGCCATCACCCTCAAGGCTATTTCAAGA-
GAATATAGCCTTGAGGGTGATGGTTTTTTGGAAA-3    .   Cdo   siRNA se-
quence #1 (  Zhang et al., 2006  ) was used in similar fashion. The pSilencer 507 CDO  –  BNIP-2  –  CDC42 SIGNALING IN MYOGENESIS   • Kang et al. 
   Perdiguero ,  E. ,  V.   Ruiz-Bonilla ,  L.   Gresh ,  L.   Hui ,  E.   Ballestar ,  P.   Sousa-Victor ,  B.  
 Baeza-Raja ,   M.    Jard í  ,   A.    Bosch-Comas ,   M.    Esteller ,   et  al .   2007 .   Genetic 
analysis of p38 MAP kinases in myogenesis: fundamental role of p38     in 
abrogating myoblast proliferation.       EMBO J.     26 : 1245  –  1256 .    
   Pownall ,   M.E. ,   M.K.    Gustafsson ,  and   C.P.    Emerson    Jr .   2002 .   Myogenic  regu-
latory factors and the specifi  cation of muscle progenitors in vertebrate 
embryos.     Annu. Rev. Cell Dev. Biol.     18 : 747  –  783 .    
   Puri ,   P.L. ,   Z.    Wu ,   P.    Zhang ,   L.D.    Wood ,   K.S.    Bhakta ,   J.    Han ,   J.R.    Feramisco , 
 M.    Karin ,  and   J.Y.J.    Wang  .   2000  .   Induction of terminal differentiation by 
constitutive activation of p38 MAP kinase in human rhabdomyosarcoma.   
  Genes Dev.     14 : 574  –  584 .  
   Riuzzi ,   F. ,   G.    Sorci ,  and   R.    Donato .   2007 .   RAGE  expression  in  rhabdomyosar-
coma cells results in myogenic differentiation and reduced proliferation, 
migration, invasiveness, and tumor growth.       Am. J. Pathol.     171 : 947  –  961 .   
   Shang ,   X. ,  Y.T.    Zhou ,  and   B.C.    Low .   2003 .   Concerted  regulation  of  cell  dynamics 
by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and 
GTPase-activating protein domains of a novel Rho GTPase-activating 
protein, BPGAP1.       J. Biol. Chem.     278 : 45903  –  45914 .    
   Shingai ,  T. ,  W.    Ikeda  ,   S.    Kakunaga ,   K.    Morimoto ,   K.   Takekuni ,   S.    Itoh ,   K.    Satoh , 
 M.    Takeuchi ,   T.    Imai ,   M.    Monden ,  and   Y.    Takai .   2003 .   Implications  of 
nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-
cell adhesion and transmembrane protein localization in epithelial cells.   
  J. Biol. Chem.     278 : 35421  –  35427 .    
   Simone ,   C. ,   S.V.    Forcales ,   D.A.    Hill ,   A.N.    Imbalzano ,   L.    Latella ,  and   P.L.    Puri . 
  2004  .   p38 pathway targets SWI-SNF chromatin-remodeling complex to 
muscle-specifi  c loci.       Nat. Genet.     36 : 738  –  743 .    
   Takaesu ,   G. ,   J.S.    Kang ,   G.U.    Bae ,   M.J.    Yi ,   C.M.    Lee ,   E.P.    Reddy , and   R.S.   
 Krauss .   2006 .   Activation  of  p38  /    MAPK in myogenesis via binding 
of the scaffold protein JLP to the cell surface protein Cdo.       J. Cell Biol.   
 175 : 383  –  388 .    
   Takano ,   H. ,   I.    Komuro ,   T.    Oka ,   I.    Shiojima ,  Y.    Hiroi ,   T.    Mizuno ,  and  Y.   Yazaki . 
  1998  .   The Rho family G proteins play a critical role in muscle differentia-
tion.     Mol. Cell. Biol.     18 : 1580  –  1589 .  
      Tapscott  ,   S.J.     2005  .   The circuitry of a master switch: Myod and the regulation of 
skeletal muscle gene transcription.       Development   .    132 : 2685  –  2695 .    
   Tenzen ,   T. ,   B.L.    Allen ,   F.    Cole ,   J.-S.    Kang ,   R.S.    Krauss ,  and   A.P.     McMahon . 
  2006  .   The cell surface membrane proteins Cdo and Boc are components 
and targets of the hedgehog signaling pathway and feedback network in 
mice.     Dev. Cell   .    10 : 647  –  656 .    
   Travaglione ,   S. ,   G.    Messina ,   A.    Fabbri ,   L.    Falzano ,   A.M.    Giammarioli ,   M.  
 Grossi ,   S.    Rufi  ni  , and   C.    Fiorentini .   2005 .   Cytotoxic  necrotizing  factor  1 
hinders skeletal muscle differentiation in vitro by perturbing the activa-
tion/deactivation balance of Rho GTPases.       Cell Death Differ.     12 : 78  –  86 .    
   Van  Aelst ,   L.  , and   C.    D ’ Souza-Schorey .   1997 .   Rho  GTPases  and  signaling  net-
works.     Genes Dev.     11 : 2295  –  2322 .    
   Wu ,   H. ,   X.    Wang ,   S.    Liu ,   Y.    Wu ,   T.    Zhao ,   X.    Chen ,   L.    Zhu ,   Y.    Wu ,   X.    Ding , 
 X.    Peng ,   et  al .   2007 .   Sema4C  participates  in  myogenic  differentiation 
in vivo and in vitro through the p38 MAPK pathway.       Eur. J. Cell Biol.   
 86 : 331  –  344 .    
   Wu ,   Z. ,   P.J.    Woodring ,   K.S.    Bhakta ,   K.    Tamura ,   F.    Wen ,   J.R.    Feramisco ,   M.  
 Karin ,   J.Y.    Wang ,  and   P.L.    Puri .   2000 .   p38  and  extracellular  signal-regulated 
kinases regulate the myogenic program at multiple steps.       Mol. Cell. Biol.   
 20 : 3951  –  3964 .    
   Yao ,   S. ,   L.    Lum ,  and   P.    Beachy .   2006 .   The  ihog  cell-surface  proteins  bind 
Hedgehog and mediate pathway activation.       Cell   .    125 : 343  –  357 .    
   Zarubin ,   T. ,  and   J.    Han .   2005 .   Activation  and  signaling  of  the  p38  MAP  kinase 
pathway.     Cell Res.     15 : 11  –  18 .    
   Zetser ,   A. ,   E.    Gredinger ,  and   E.    Bengal .   1999 .   p38  mitogen-activated  protein 
kinase pathway promotes skeletal muscle differentiation. Participation of 
the Mef2c transcription factor.       J. Biol. Chem.     274 : 5193  –  5200 .    
   Zhang ,   W. ,   J.-S.    Kang ,   F.    Cole ,   M.J.   Yi ,  and   R.S.    Krauss .   2006 .   Cdo  functions  at 
multiple points in the Sonic Hedgehog pathway, and Cdo-defi  cient mice 
accurately model human holoprosencephaly.       Dev. Cell   .    10 : 657  –  665 .    
   Zhou ,  Y.T. ,   G.R.    Guy ,  and   B.C.    Low .   2005 .   BNIP-2  induces  cell  elongation  and 
membrane protrusions by interacting with Cdc42 via a unique Cdc42-
binding motif within its BNIP-2 and Cdc42GAP homology domain.       Exp. 
Cell Res.     303 : 263  –  274 .              
   Cole ,   F. ,  W.    Zhang ,  A.    Geyra ,   J.-S.    Kang ,  and   R.S.    Krauss .   2004 .   Positive  regula-
tion of myogenic bHLH factors and skeletal muscle development by the 
cell surface receptor CDO.       Dev. Cell   .    7 : 843  –  854 .    
   Cole ,   S.J. ,   D.    Bradford ,  and   H.M.    Cooper .   2007 .   Neogenin:  a  multi-functional 
receptor regulating diverse developmental processes.       Int. J. Biochem. 
Cell Biol.     39 : 1569  –  1575 .    
   Coso ,   O.A. ,   M.    Chiariello ,   J.-C.   Yu ,   H.    Teramoto ,   P.    Crespo ,   N.    Xu ,   T.    Miki ,  and 
  J.S.     Gutkind  .   1995  .   The small GTP-binding proteins Rac1 and Cdc42 regu-
late the activity of the JNK/SAPK signaling pathway.       Cell   .    81 : 1137  –  1146 .   
   Cuenda ,   A. ,  and   P.     Cohen  .   1999  .   Stress-activated protein kinase-2/p38 and a 
rapamycin-sensitive pathway are required for C2C12 myogenesis.       J. Biol. 
Chem.     274 : 4341  –  4346 .    
   Dickson ,   B.J. ,  and   G.F.    Gilestro .   2006 .   Regulation  of  commissural  axon 
pathfi  nding by slit and its Robo receptors.       Annu. Rev. Cell Dev. Biol.   
 22 : 651  –  675 .    
   Gallo ,   R. ,   M.    Serafi   ni ,   L.    Castellani ,   G.    Falcone ,  and   S.    Alem à  .   1999 .   Distinct 
effects of Rac1 on differentiation of primary avian myoblasts.       Mol. Biol. 
Cell   .    10 : 3137  –  3150 .  
   Jaffe ,   A.B. ,  and   A.    Hall .   2005 .   Rho  GTPases:  biochemistry  and  biology.     Annu. 
Rev. Cell Dev. Biol.     21 : 247  –  269 .    
   Jones ,   N.C. ,   K.J.    Tyner ,   L.    Nibarger ,   H.M.    Stanley ,   D.D.    Cornelison ,  Y.V.    Fedorov , 
and   B.B.    Olwin .   2005 .  The  p38  /    MAPK functions as a molecular switch 
to activate the quiescent satellite cell.       J. Cell Biol.     169 : 105  –  116 .    
   Kang ,   J.-S. ,   P.J.    Mulieri ,   C.    Miller ,   D.A.    Sassoon ,  and   R.S.    Krauss .   1998 .   CDO,  a 
Robo-related cell surface protein that mediates myogenic differentiation.   
  J. Cell Biol.     143 : 403  –  413 .    
   Kang ,   J.-S. ,   P.J.    Mulieri ,   Y.    Hu ,   L.    Taliana ,  and   R.S.    Krauss .   2002 .   BOC,  an  Ig 
superfamily member, associates with CDO to positively regulate myo-
genic  differentiation.     EMBO J.     21 : 114  –  124 .    
   Kang ,   J.-S. ,   J.L.    Feinleib ,   S.    Knox ,   M.A.    Ketteringham ,  and   R.S.    Krauss . 
  2003  .   Pro-myogenic members of the Ig and cadherin families associ-
ate to positively regulate differentiation.       Proc. Natl. Acad. Sci. USA   .  
 100 : 3989  –  3994 .    
   Kang ,   J.-S. ,   M.-J.    Yi ,   W.    Zhang ,   J.L.    Feinleib ,   F.    Cole ,  and   R.S.    Krauss . 
  2004  .   Netrins and neogenin promote myotube formation.       J. Cell Biol.   
 167 : 493  –  504 .    
   Ko ,   J.A. ,   T.    Gondo ,   S.    Inagaki ,  and   M.    Inui .   2005 .   Requirement  of  the  trans-
membrane semaphorin Sema4C for myogenic differentiation.       FEBS Lett.   
 579 : 2236  –  2242 .    
   Lluis ,   F. ,   E.    Ballestar ,   M.     Suelves  ,   M.     Esteller  , and   P.     Munoz-Canoves .   2005 . 
  E47 phosphorylation by p38 MAPK promotes MyoD/E47 association 
and muscle-specifi  c gene transcription.       EMBO J.     24 : 974  –  984 .    
   Lluis ,   F. ,   E.    Perdiguero ,  A.R.    Nebreda ,  and   P.    Munoz-Canoves .   2006 .   Regulation 
of skeletal muscle gene expression by p38 MAP kinases.       Trends Cell 
Biol.     16 : 36  –  44 .    
   Lovett ,   F.A. ,   I.    Gonzalez ,   D.A.    Salih ,   L.J.    Cobb ,   G.    Tripathi ,   R.A.    Cosgrove ,   A.  
 Murrell ,   P.J.    Kilshaw ,  and   J.M.    Pell .   2006 .   Convergence  of  Igf2  expres-
sion and adhesion signalling via RhoA and p38 MAPK enhances myo-
genic  differentiation.     J. Cell Sci.     119 : 4828  –  4840 .    
   Low ,   B.C. ,   Y.P.    Lim ,   J.    Lim ,   E.S.    Wong ,  and   G.R.    Guy .   1999 .   Tyrosine  phos-
phorylation of the Bcl-2-associated protein BNIP-2 by fi  broblast growth 
factor receptor-1 prevents its binding to Cdc42GAP and Cdc42.       J. Biol. 
Chem.     274 : 33123  –  33130 .    
   Low ,  B.C. ,  K.T.   Seow , and  G.R.   Guy .  2000a .  Evidence for a novel Cdc42GAP domain 
at the carboxyl terminus of BNIP-2.       J. Biol. Chem.     275 : 14415  –  14422 .    
   Low ,   B.C. ,   K.T.    Seow ,  and   G.R.    Guy .   2000b .   The  BNIP-2  and  Cdc42GAP  ho-
mology domain of BNIP-2 mediates its homophilic association and het-
erophilic interaction with Cdc42GAP.       J. Biol. Chem.     275 : 37742  –  37751 .   
   Martinelli ,   D.C. ,  and   C.M.    Fan .   2007 .   Gas1  extends  the  range  of  Hedgehog  ac-
tion by facilitating its signaling.       Genes Dev.     21 : 1231  –  1243 .    
   Meriane ,   M. ,   S.    Charrasse ,   F.    Comunale ,   A.    Mery ,   P.    Fort ,   P.    Roux ,  and   C.  
  Gauthier-Rouviere  .   2000  .   Critical activities of Rac1 and Cdc42Hs in 
skeletal myogenesis: antagonistic effects of JNK and p38 pathways.       Mol. 
Biol. Cell   .    11 : 2513  –  2528 .  
   Minden ,   A. ,   A.    Lin ,   F.-X.    Claret ,   A.    Abo ,  and   M.    Karin .   1995 .   Selective  activa-
tion of the JNK signaling cascade and c-Jun transcription activity by the 
small GTPases Rac and Cdc42Hs.       Cell   .    81 : 1147  –  1157 .    
   Moln á r ,  A. ,  A.M.   Theodoras ,  L.I.   Zon , and  J.M.   Kyriakis .  1997 .  Cdc42Hs, but not 
Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a 
mechanism requiring p38/RK.       J. Biol. Chem.     272 : 13229  –  13235 .    
   Morgenstern ,   J.P. ,  and   H.     Land  .   1990  .   Advanced mammalian gene transfer: high ti-
ter retroviral vectors with multiple drug selection markers and a complemen-
tary helper-free packaging cell line.       Nucleic Acids Res.     18 : 3587  –  3596 .    
   Mulieri ,   P.J. ,   A.    Okada ,   D.A.    Sassoon ,   S.K.    McConnell ,  and   R.S.    Krauss . 
  2000  .   Developmental expression pattern of the   cdo   gene.     Dev. Dyn.   
 219 : 40  –  49 .    